Ulrich Femoe Membe, Hermine Boukeng Jatsa, Th�©ophile Dimo and Louis albert Tchuem Tchuente
University of Yaound�© 1, Cameroon
Centre for Schistosomiasis and Parasitology, Cameroon
Posters & Accepted Abstracts: J Neurol Neurophysiol
Background: Schistosomiasis (bilharziasis) is an infectious parasitic disease caused by blood flukes of the genus Schistosoma. Schistosomiasis is an important public health problem in Africa. After malaria, it is the second most prevalent tropical disease, affecting at least 258 million people worldwide and 90% in Africa (WHO, 2017). The eggs released by the adult female worm are mainly responsible to the pathology where they are deposited in the liver, intestine, uro-genital or Central Nervous System (CNS). The most severe clinical outcome associated with this parasite is the infection of the central nervous system (CNS) known as neuroschistosomiasis (NSM) and can affect the brain or the spinal cord occurring during all phases of schistosomiasis and resulting to severe complications. Chronic neuroschistosomiasis results from the hostâ��s immune response to the eggs and the resultant granulomatous reaction and fibro-obstructive disease. Once deposited into CNS, the mature embryo secretes immunogenic substances that causing inflammatory reaction leading to a peri-ovular granulomatous reaction. In the early phase of schistosomiasis (the first 110 days) the immune response reaches maximum intensity. The granulomas successfully destroy the ova, but result in fibrotic deposition in the host tissue. The mass effect of thousands of eggs and the large granulomas concentrated within the brain or spinal cord leads to symptoms such as headache, focal or generalized seizures, ataxia, nystagmus, nausea and vomiting, intracranial hypertension and neurological deficit. Purpose: Many clinical cases have been reported by several authors and any experimental study has been performed to evaluate the immunopathology and diagnosis during CNS invasion by Schistosoma. Moreover, there is no definitive consensus regarding therapy of NSM. Therefore, the search for alternative or complementary drugs has become a priority. Then, Sida pilosa and Ozoroa pulcherrima is good drug candidate against Schistosoma infection. These plants have been studied and showed schistosomicidal effects (in-vitro and in-vivo), antifibrotic and anti-inflammatory activities (in-vivo) on mice liver infected by Schistosoma mansoni. We aimed for our PhD research to evaluate neuroprotective and neuro-immunomodulatory effects of these plants extracts on mice model of neuroschistosomiasis induced by Schistosoma mansoni. Experimental Design: The research design will consist to infect mice with Schistosoma mansoni cercariae (80 cercariae per mouse). 12 weeks after untreated and treated mice will go through the behavioral and neurocognitive tests (open field, traction test, and T maze) and sacrificed. Histological and immunohistochemical analyses performed to evaluate inflammation and necrosis in brain and spinal cord tissue as well as inflammatory and pro-fibrotic biomarkers (INF-�¥, TNF-�±, IL-10; IL-13, NF�º-b, BDNF and C-reactive protein) in serum and brain tissue. ulrichfemoe10@gmail.com
